Trials

  • October 28, 2026

    DOD Contractor Owes $1.2M In Whistleblower Suit, Jury Says

    An ex-employee of a U.S. Department of Defense contractor won a $1.2 million award after a Colorado federal jury found the contractor liable for wrongful discharge and violations of the Defense Contractor Whistleblower Protection Act, according to the final judgment, entered Wednesday. 

  • October 28, 2026

    UMC Settles Suit Over Ex-Panasonic Chip Patents Before Trial

    Taiwanese chipmaker United Microelectronics Corp. notified a Texas federal court Tuesday that it has agreed to settle a suit alleging that it infringed seven semiconductor patents originally issued to Japan's Panasonic Corp., days before a trial was set to begin.

  • October 28, 2026

    Versata Wants Ford To Pay Interest Atop Restored $82M Award

    Versata Software Inc. wants a Michigan federal court to tack on at least $37.7 million to a reinstated $82.3 million contract award against Ford Motor Co. and said the court should finalize that win while both sides prepare for a new trade secret damages trial.

  • October 28, 2026

    Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial

    Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly sought to thwart competition for its single-use insulin injector pen.

  • October 28, 2026

    Judge Hellerstein, Gruff Moderator Of Major Cases, Dies At 92

    Judge Alvin K. Hellerstein, a former litigator and sometimes impatient Manhattan federal jurist who presided over decades of high-profile cases that often came under close appellate scrutiny, died Wednesday at the age of 92.

  • October 27, 2026

    At 4th Circ., DOJ Admits But Downplays Goldstein Trial Errors

    The U.S. Department of Justice late Tuesday acknowledged that it confused key statutory terms related to jury instructions at famed appellate advocate Tom Goldstein's criminal trial, while also insisting "the government's mistake here was understandable" and shouldn't upend a jury's guilty verdict.

  • October 27, 2026

    3 Federal Circuit Clashes To Watch In November

    A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are among the arguments the Federal Circuit will hear in November.

  • October 27, 2026

    Mallet Wins Injunction On Release Of Baking Product Secrets

    Baking product company Mallet & Co. was granted a permanent injunction Tuesday to stop a rival from accessing or disclosing its trade secrets after a federal judge ordered the rival to pay $11.4 million in legal bills for sharing copied goods in publicly accessible court documents.

  • October 27, 2026

    Soldier Can't Slip Charges Over Maduro Raid Polymarket Bet

    A U.S. Army soldier must face charges that he profited from insider knowledge of the raid that captured deposed Venezuelan President Nicolás Maduro after a Manhattan federal judge ruled that whether his prediction market trades ran afoul of commodities laws is a question for trial.

  • October 27, 2026

    Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

    Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.

  • October 27, 2026

    RE Execs, Brother Get 30 Years For 'Monstrous' Sex Assaults

    A Manhattan federal judge hit two wealthy former real estate executives and their brother with 30 years each in prison Tuesday, after a jury convicted the three Florida men of a 13-year campaign of trafficking, drugging and raping women and minors.

  • October 27, 2026

    Daily Mail, Publishers Fight Google's 'Multi-Year Delay'

    Gannett, the Daily Mail and a certified class of website publishers urged a New York federal judge Monday not to let Google pause a scheduled advertising placement technology trial, arguing in twin briefs that the U.S. Department of Justice's antitrust win is strong and Google's appeal won't disrupt the multidistrict litigation.

  • October 27, 2026

    ​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

    A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.

  • October 26, 2026

    Google Says DOJ Overreaching With Proposed Antitrust Fixes

    Google has told a D.C. federal court that the U.S. Department of Justice and state enforcers are trying to force it into unreasonable antitrust measures that go beyond what the court imagined when it handed down its remedies order in the monopolization suit.

  • October 26, 2026

    Meta Docs Reveal Plan To Discredit Teen-Harm Critic Haidt

    Meta internally set a goal to "get the academic community to disavow" and "turn against" professor Jonathan Haidt, who has linked social media use to mental health decline, as it in-house rebuffed internal efforts to study social media's impact on teen health, according to recently unredacted documents filed publicly Friday.

  • October 26, 2026

    Trump Media Investor Says Firm Reaped $18M On Inside Info

    A Trump Media & Technology Group Corp. shareholder told jurors in Florida federal court on Monday that the $18 million a venture capital firm made when Trump Media went public should be returned because it was the result of insider trading.

  • October 26, 2026

    Salsa Producer Had Rights To 3 Albums, Jury Finds

    A federal jury in Miami came back with a mixed verdict Friday in a dispute between a Venezuelan salsa composer and his former business partner and producer, finding the producer had a valid license for three of the six albums at issue and owned one of two trademarks.

  • October 26, 2026

    Pa. Court Affirms $9.5M Verdict Over Botched Vasectomy

    A Pennsylvania appellate panel Monday affirmed a $9.5 million verdict in a suit accusing a doctor of botching a man's vasectomy that caused the loss of a testicle, saying the verdict was supported by sufficient evidence.

  • October 26, 2026

    Comcast, Viamedia Settle Cable Ad Antitrust Case Before Trial

    Comcast Corp. and Viamedia Inc. have reached a settlement in their decadelong antitrust battle over the cable advertising market just days before a jury trial was set to begin in Illinois federal court over allegations the cable giant is monopolizing local advertising markets.

  • October 26, 2026

    In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

    A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.

  • October 26, 2026

    Mich. Panel Backs $9.7M Negligence Verdict Against Hospital

    A Michigan appeals court declined to upend a hospital's share of a $9.7 million jury verdict for administrative negligence in its care for a woman who died while receiving emergency treatment for complications following an abdominoplasty, or "tummy tuck" procedure.

  • October 26, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week approved a $250 million settlement of litigation over Microsoft Corp.'s acquisition of Activision Blizzard Inc., while Albertsons Cos. Inc. accused Kroger Co. of rejecting changes that could have saved their $24.6 billion merger, and the Delaware Supreme Court ordered Verisk Analytics Inc. to keep pursuing a $2.35 billion acquisition.

  • October 26, 2026

    Radiology Co. Strikes Deal In ESOP Fight Ahead Of Trial

    Radiology company Envision and its trustee have settled a class action claiming they brokered an inflated $163.7 million stock sale to the business' employee stock ownership plan, staving off a bench trial that was days away from kicking off, according to a Colorado federal court filing.

  • October 23, 2026

    Teva, Eli Lilly Spar Over Possible New Drug Patent Trial

    Eli Lilly and Teva on Friday sparred over whether a new trial should be held in Massachusetts federal court over the validity of patents related to Teva's migraine drug Ajovy after the Federal Circuit reversed the Boston court's judgment that favored Eli Lilly.

  • October 23, 2026

    'Millennial VC' Loses New Trial Bid Over Alleged Atty Failure

    A California federal judge on Thursday denied convicted self-described "millennial" venture capitalist Michael Rothenberg's latest new trial bid, rejecting his argument that his prior counsel's failure to consult a forensic accountant undermined his defense nearly three years after a jury found him guilty of money laundering and fraud.

Expert Analysis

  • NY Art Ruling Creates Fault Line In Cultural Property Cases

    Author Photo

    A recent New York state appellate decision, blocking a Holocaust victim’s heirs from using a criminal turnover order to reclaim a work the Art Institute of Chicago says it acquired legally, makes establishing ownership a newly central question in cultural property disputes, says Duncan Levin at Levin & Associates.

  • Testing AI's Promise For Large-Scale Document Review

    Author Photo

    Our document-review comparison of attorneys' responsiveness and issue coding decisions versus predictions generated by artificial intelligence across 1,600 documents suggests that these tools can offer a reasonable and reliable basis for improved discovery workflows, provided lawyers understand where guardrails are needed, say attorneys at Redgrave.

  • AI Meeting Recaps Pose New Discovery And Privilege Risks

    Author Photo

    The New York City Bar Association’s recent ethics opinion, cautioning attorneys not to record nonclient conversations with artificial intelligence tools, reflects an emerging view that AI meeting recaps are now a distinct business record category, meaning counsel should set meeting-level controls and apply framework-level updates, says William Wright at Faegre Drinker.

  • $95M Nev. Case Provides Clues On Wound Care Enforcement

    Author Photo

    Federal prosecutors’ recent U.S. v. Dubin indictment, charging a Nevada physician with healthcare fraud over an alleged $95 million Medicare billing scheme involving amniotic wound allografts, provides a clearer picture of an increasingly data-driven enforcement strategy that follows the entire wound care transaction, say attorneys at Bass Berry.

  • First Steps For Companies Facing AI-Assisted Pro Se Suits

    Author Photo

    As the volume of filings by pro se litigants assisted by artificial intelligence tools continues to increase, companies should adopt a consistent early assessment process to control costs while responding fairly and effectively to such claims, say attorneys at Stradley Ronon.

  • 4 Tips On Expert Gatekeeping From J&J Talc Deal

    Author Photo

    Johnson & Johnson's successful campaign to exclude plaintiff-side oncologist testimony about whether its talcum powder caused ovarian cancer, which prompted the recent resolution of 70,000 claims, offers lessons on how product liability defendants can reshape risk calculation by rigorously applying expert admissibility rules, say attorneys at Hollingsworth.

  • Series

    Playing Bid Whist Makes Me A Better Lawyer

    Author Photo

    As a child, I viewed bid whist as a family tradition and a source of friendly card game competition, but as a lawyer, I see it as a tool that has helped me cultivate skills like communication, teamwork, risk assessment and composure, says Keyonn Pope at Riley Safer.

  • What Greek Tragedy Teaches About Mediating AI Disputes

    Author Photo

    While ancient Greek writers could not have anticipated modern arbitration, their tragic plays illustrate new and familiar questions for mediators dealing with artificial intelligence disputes, including the functional differences between adjudication and resolution, says Giuseppe De Palo at JAMS.

  • Teva, Wyeth Show How Claimed Advances Shape Enablement

    Author Photo

    Two recent Federal Circuit decisions involving method-of-treatment claims — Teva v. Eli Lilly and Wyeth v. AstraZeneca — reached opposite enablement outcomes from strikingly similar procedural postures, but a closer comparison of the cases reveals a three-step framework for understanding the court's reasoning, says Kendall Gurule at Polsinelli.

  • Opinion

    Calif. Bill Goes Too Far In Trying To Regulate Attorney AI Use

    Author Photo

    California’s first-in-the-nation act regulating how attorneys and arbitrators use generative artificial intelligence will likely soon become law, but read broadly, the provisions may dissuade lawyers from employing AI at all, thereby depriving them of key work tools, says Joshua Wurtzel at Schlam Stone.

  • Reel Justice: 'The Furious' And Journalistic Evidence

    Author Photo

    Viewing "The Furious” from a litigator’s perspective highlights nuances that arise when gathering evidence from journalistic investigations, serving as a reminder to not only ask whether evidence is relevant, but also what legal framework governs the person or entity holding it, says Veronica Finkelstein at Widener-Delaware Law.

  • Resetting For Success After Corporate Litigation Loses Focus

    Author Photo

    Corporate litigation that has lost strategic coherence may barrel disastrously ahead if counsel’s understanding of the matter drifts from the client’s goals, but cases can be wrenched back on track by diagnosing how facts have evolved, determining where resources are justified and deploying practical strategies for restoring discipline, says Jonathan Morris at Gordon Rees.

  • How Bifurcation And Verdict Forms Can Sway Jury Outcomes

    Author Photo

    The bifurcated trial structure used in a Nevada personal injury case — where the jury recently awarded the plaintiff more than $56 million — highlights a strategic option that litigators often overlook and raises considerations about the potential advantage of carefully assembled verdict forms, says litigation consultant Clint Townson.

  • Meta Deal Highlights Advisory Jury Issues, Litigation Risk

    Author Photo

    The $17 billion settlement of youth safety claims brought against Meta offers lessons for all consumer-facing companies because the court made the rare move of empaneling an advisory jury and the case was built on what the company learned from its own studies, says Mark Morgan at McCarter & English.

  • 2nd Circ. Tylenol MDL Ruling Clarifies Court Gatekeeper Role

    Author Photo

    The Second Circuit’s recent decision in multidistrict litigation over alleged links between Tylenol and developmental disorders, holding that the trial court improperly excluded expert witnesses, preserves meaningful judicial gatekeeping while making clear that judges may not resolve legitimate scientific disputes themselves, say attorneys at Lowenstein Sandler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Trials archive.